MicroIslet Announces Voluntary Reorganization Filing
10 nov. 2008 17h57 HE
|
MicroIslet, Inc.
SAN DIEGO, Nov. 10, 2008 (GLOBE NEWSWIRE) -- MicroIslet Inc. (OTCBB:MIIS) (http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for...
MicroIslet Completes a $1 Million Private Placement
16 nov. 2007 08h30 HE
|
MicroIslet, Inc.
SAN DIEGO, Nov. 16, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) is a biotechnology company engaged in the development and commercialization of encapsulated islet cells for transplantation...
MicroIslet Announces the Appointment of Amaresh Basu, Ph.D. as Vice President, Research and Development, and the Retention of Regulus Pharmaceutical Consulting
15 oct. 2007 09h00 HE
|
MicroIslet, Inc.
SAN DIEGO, Oct. 15, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) announced today that Amaresh Basu, Ph.D. has been named Vice President, Research and Development. Separately, MicroIslet...
Barry Ritholtz, Noted Stock Market Analyst, Appointed to the Board of Directors of MicroIslet
26 sept. 2007 08h35 HE
|
MicroIslet, Inc.
SAN DIEGO, Sept. 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Barry Ritholtz has been named to the Company's Board of Directors.
"I am very excited...
MicroIslet Receives $1 Million Working Capital Loan
21 sept. 2007 09h30 HE
|
MicroIslet, Inc.
SAN DIEGO, Sept. 21, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS), a development-stage biotechnology company with patented and proprietary technologies focused on transplantation therapy for...
MicroIslet and Progenitor Cell Therapy Enter Into Agreement for the Manufacturing of MicroIslet-P, an Encapsulated Islet Cell Product for the Treatment of Type 1 Diabetes
17 sept. 2007 10h05 HE
|
MicroIslet, Inc.
SAN DIEGO and HACKENSACK, N.J., Sept. 17, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS), a development-stage biotechnology company with patented and proprietary technologies focused on...
MicroIslet, Inc. Files Quarterly Report On Form 10-QSB for Second Quarter 2007
21 août 2007 09h30 HE
|
MicroIslet, Inc.
SAN DIEGO, Aug. 21, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) announced that it filed its Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007, with the Securities and...
MicroIslet Implements Staffing Changes to Further the Company's New Corporate Strategy
23 juil. 2007 09h00 HE
|
MicroIslet, Inc.
SAN DIEGO, July 23, 2007 (PRIME NEWSWIRE) -- As previously announced, MicroIslet, Inc. (OTCBB:MIIS) (the "Company") has refocused its efforts to accelerate the clinical testing of the Company's...
Jonathan Lakey, Co-Developer of the Edmonton Protocol, Named President, and Michael J. Andrews Appointed Chief Executive Officer of MicroIslet
05 juil. 2007 14h40 HE
|
MicroIslet, Inc.
SAN DIEGO, July 5, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R.T. Lakey, Ph.D., M.S.M., has been named as President of MicroIslet, and...
Edmonton Protocol Diabetes Islet Cell Pioneer Named Chief Scientific Officer of MicroIslet
26 juin 2007 12h34 HE
|
MicroIslet, Inc.
SAN DIEGO, June 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R. T. Lakey, Ph.D., M.S.M., was named the Company's Chief Scientific Officer...